Diabetes 52:2975-2983, 2003
© 2003 by the American Diabetes Association, Inc.
Connective Tissue Growth Factor and IGF-I Are Produced by Human Renal Fibroblasts and Cooperate in the Induction of Collagen Production by High Glucose
Suzanne Lam1,
Reinier N. van der Geest1,
Nicole A.M. Verhagen1,
Frans A. van Nieuwenhoven2,
Ingrid E. Blom2,
Jan Aten3,
Roel Goldschmeding2,
Mohamed R. Daha1, and
Cees van Kooten1
1 Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands
2 Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands
3 Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands
Tubulointerstitial fibrosis is an important component in the development of diabetic nephropathy. Various renal cell types, including fibroblasts, contribute to the excessive matrix deposition in the kidney. Although transforming growth factor-ß (TGF-ß) has been thought to play a major role during fibrosis, other growth factors are also involved. Here we examined the effects of connective tissue growth factor (CTGF) and IGF-I on collagen type I and III production by human renal fibroblasts and their involvement in glucose-induced matrix accumulation. We have demonstrated that both CTGF and IGF-I expressions were increased in renal fibroblasts under hyperglycemic conditions, also in the absence of TGF-ß signaling. Although CTGF alone had no effect on collagen secretion, combined stimulation with IGF-I enhanced collagen accumulation. Furthermore, IGF-I also had a synergistic effect with glucose on the induction of collagens. Moreover, we observed a partial inhibition in glucose-induced collagen secretion with neutralizing anti-CTGF antibodies, thereby demonstrating for the first time the involvement of endogenous CTGF in glucose-induced effects in human renal fibroblasts. Therefore, the cooperation between CTGF and IGF-I might be involved in glucose-induced matrix accumulation in tubulointerstitial fibrosis and might contribute to the pathogenesis of diabetic nephropathy.
Address correspondence and reprint requests to Dr. Cees van Kooten, Leiden University Medical Center, Department of Nephrology, C3P, Albinusdreef 2, 2333 ZA Leiden, Netherlands. E-mail: Kooten{at}lumc.nl

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Tosetti, D. M. Noonan, and A. Albini
Choking hypoxia-inducible factor 1alpha: a novel mechanism for connective tissue growth factor inhibition of angiogenesis.
J Natl Cancer Inst,
July 19, 2006;
98(14):
946 - 948.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Roestenberg, F. A. van Nieuwenhoven, J. A. Joles, C. Trischberger, P. P. Martens, N. Oliver, J. Aten, J. W. Hoppener, and R. Goldschmeding
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice
Am J Physiol Renal Physiol,
June 1, 2006;
290(6):
F1344 - F1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Aikawa, J. Gunn, S. M. Spong, S. J. Klaus, and M. Korc
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer
Mol. Cancer Ther.,
May 1, 2006;
5(5):
1108 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Si, Q. Kang, H. H. Luu, J. K. Park, Q. Luo, W.-X. Song, W. Jiang, X. Luo, X. Li, H. Yin, et al.
CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells
Mol. Cell. Biol.,
April 15, 2006;
26(8):
2955 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Huang, L.-Y. Chuang, J.-Y. Guh, C.-J. Chen, Y.-L. Yang, T.-A. Chiang, M.-Y. Hung, and T.-N. Liao
Effect of Nitric Oxide-cGMP-Dependent Protein Kinase Activation on Advanced Glycation End-Product-Induced Proliferation in Renal Fibroblasts
J. Am. Soc. Nephrol.,
August 1, 2005;
16(8):
2318 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. van Nieuwenhoven, L. J. N. Jensen, A. Flyvbjerg, and R. Goldschmeding
Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?
Nephrol. Dial. Transplant.,
January 1, 2005;
20(1):
6 - 10.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Luo, Q. Kang, W. Si, W. Jiang, J. K. Park, Y. Peng, X. Li, H. H. Luu, J. Luo, A. G. Montag, et al.
Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells
J. Biol. Chem.,
December 31, 2004;
279(53):
55958 - 55968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zhou, C. Li, and L. Cai
Advanced Glycation End-Products Induce Connective Tissue Growth Factor-Mediated Renal Fibrosis Predominantly through Transforming Growth Factor {beta}-Independent Pathway
Am. J. Pathol.,
December 1, 2004;
165(6):
2033 - 2043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Roestenberg, F. A. van Nieuwenhoven, L. Wieten, P. Boer, T. Diekman, A. M. Tiller, W. M. Wiersinga, N. Oliver, W. Usinger, S. Weitz, et al.
Connective Tissue Growth Factor Is Increased in Plasma of Type 1 Diabetic Patients With Nephropathy
Diabetes Care,
May 1, 2004;
27(5):
1164 - 1170.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|